SYSTM Wealth Solutions’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-5,663
Closed -$2.76M 345
2024
Q2
$2.76M Buy
5,663
+284
+5% +$143K 0.62% 58
2024
Q1
$2.9M Buy
5,379
+402
+8% +$220K 0.37% 77
2023
Q4
$2.76M Buy
4,977
+567
+13% +$266K 0.38% 68
2023
Q3
$1.93M Buy
4,410
+193
+5% +$96.2K 0.3% 93
2023
Q2
$2.12M Buy
4,217
+150
+4% +$71.9K 0.29% 91
2023
Q1
$2.03M Buy
4,067
+9
+0.2% +$4.31K 0.31% 79
2022
Q4
$1.66M Buy
+4,058
New +$1.58M 0.21% 142

Other funds holding IDXX

SYSTM Wealth Solutions's IDXX Position: Q3 2024 in Review

SYSTM Wealth Solutions sold out of Idexx Laboratories (IDXX) in Q3 2024, closing a stake of 5,663 shares — an estimated $2.76M sold.

SYSTM Wealth Solutions first reported a position in IDXX in Q4 2022 and held it in 7 quarters. The position peaked at $2.9M in Q1 2024. 1,115 funds tracked by Wall St. Rank hold IDXX as of Q3 2024.

  • SYSTM Wealth Solutions reported no remaining Idexx Laboratories position as of Q3 2024 after selling out during the quarter.
  • SYSTM Wealth Solutions sold 5,663 Idexx Laboratories shares in Q3 2024, an estimated $2.76M.
  • SYSTM Wealth Solutions first reported a position in Idexx Laboratories in Q4 2022 and held it in 7 quarters.
  • SYSTM Wealth Solutions's Idexx Laboratories position peaked at $2.9M in Q1 2024.
  • 1,115 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2024.

Based on SYSTM Wealth Solutions's 13F filing for Q3 2024, filed 14 Nov 2024.